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Prolyl-hydroxyproline (Pro-Hyp) is one of the major constituents of collagen-derived dipeptides. The 
objective of this study was to investigate the effects of Pro-Hyp on the proliferation and 
differentiation of MC3T3-E1 osteoblastic cells. Addition of Pro-Hyp did not affect MC3T3-E1 cell 
proliferation and matrix mineralization but alkaline phosphatase activity was significantly increased. 
Furthermore, cells treated with Pro-Hyp significantly upregulated gene expression of Runx2, Osterix, 
and Col1α1. These results indicate that Pro-Hyp promotes osteoblast differentiation. This study 
demonstrates for the first time that Pro-Hyp has a positive effect on osteoblast differentiation with 
upregulation of Runx2, Osterix, and Collα1 gene expression. 
 




Pro-Hyp, Prolyl-hydroxyproline; α-MEM, alpha-modified Eagle’s medium; FBS, fetal bovine 





Collagen is a key extracellular matrix protein present mainly in skin and bone. Gelatin is a 
denatured form of collagen and collagen-derived peptides (CP) is formed by protease hydrolysis of 
this gelatin. Various di- or tripeptides are included in CP. Furthermore, it is thought that collagen in 
living tissues is degraded into collagen peptides by various enzymes secreted by osteoclasts or 
osteoblasts during the process of bone metabolism [1,2]. CP can be derived not only from food but 
also from collagen in connective tissues such as skin and bone. 
Several food-derived collagen oligopeptides were identified in human blood after oral 
ingestion of CP [3,4]. Prolyl-hydroxyproline (Pro-Hyp) is the major constituent of CP, which remains 
within human blood after ingestion of CP [5-7]. Pro-Hyp or hydroxyproline-containing peptides are 
hard to be hydrolyzed in vivo and may play important functions in target tissues [8]. It has been 
reported that Pro-Hyp affects the growth of fibroblasts and regulates the differentiation of 
chondrocytes [9,10].  
A previous study has shown that oral administration of CP increases bone mineral density 
in calcium-deficient rats [11]. Furthermore, some studies have indicated that crude CP has a 
beneficial effect on the proliferation or differentiation of osteoblastic cells [12-14]. Therefore, CP 
may also play an important role in bone remodeling. However, the role of specific sequences peptide 
including in CP on bone metabolism is currently unclear. In this study, we investigated the effect of 
Pro-Hyp on the proliferation and differentiation of MC3T3-E1 osteoblastic cells. 
  
Materials and Methods 
 
Cell culture 
Mouse calvarial, osteoblastic cell line, MC3T3-E1 cells were cultured in growth medium 
comprising alpha-modified Eagle’s medium (α-MEM) supplemented with 10% fetal bovine serum 
(FBS, Gibco, Carlsbad, CA, USA) and 100 U/mL penicillin. Cell cultures were maintained at 37°C 
in a humidified atmosphere of 5% CO2. For mineralization analysis, growth medium was replaced 
with osteoblast differentiation medium (ODM) comprising α-MEM supplemented with 10% FBS, 5 
mmol/L β-glycerophosphate, 1 nmol/L dexamethasone, and 100 μg/mL ascorbic acid.  
 
Cell proliferation 
Cells were seeded in a 96-well plate at a density of 3×103 cells/well and cultured for 3 h in 
growth medium. Medium was then replaced with identical medium containing Pro-Hyp (0.01, 0.1, 
and 1 mM, Bachem, Heidelberg, Germany). Cells were cultured with or without Pro-Hyp and cell 
proliferation was measured on day 2 of culture using the WST-1 assay (Cell Counting Kit; Dojindo 
Laboratories, Kumamoto, Japan). Plates were read using a microplate reader (Perkin Elmer, Inc,, 
Waltham, MA, USA) at a wavelength of 450 nm. 
 Alkaline phosphatase (ALP) activity 
Cells were cultured to confluence and growth medium was replaced with identical medium 
containing 0.1 or 1 mM Pro-Hyp. Cells were cultured for an additional 5 days. After incubation, cells 
were fixed with 20% formalin for 10 min and incubated in 0.05 mol/L 2-amino-2-methyl-1-propanol 
(AMP) buffer (pH 9.8), containing 10 mM naphtol AS-BI phosphate and 1 mM fastred violet LB salt 
for 30 min at 37°C. The staining solution was aspirated and the cells were washed with deionized 
water [15]. The ALP stained areas were scanned using an image scanner and analyzed qualitatively 
using Image J software. 
 
Mineralization assay 
Cells cultured for 21 days in ODM and ODM + Pro-Hyp (0.1 and 1 mmol/L). ODM was 
changed every 2 days. After incubation, cells were washed with PBS and fixed with 4% 
paraformaldehyde for 30 min. Cells were then washed twice with deionized water and 5% silver 
nitrate was added. Cells were exposed to ultraviolet (UV) light for 15 h. Finally, the cells were fixed 
with 5% sodium thiosulfate for 5 min [16]. Mineralized nodules were scanned using an image 
scanner and analyzed qualitatively using Image J software. 
 Quantitative real-time polymerase chain reaction (PCR) 
MC3T3-E1 cells were seeded in growth medium in a six-well plate at a density of 9×104 
cells/well. After culturing for 3 days, the medium was then replaced with identical medium 
containing 0.1 and 1 mM Pro-Hyp. The cells were cultured with or without Pro-Hyp for 3 h. Total 
RNA was extracted from the cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). 
First-strand cDNA was converted with the PrimeScript™ reagent kit (Takara Bio Japan, Shiga, 
Japan). Quantitative real-time PCR was performed using the TaqMan gene expression assay 
(Applied Biosystems, Carlsbad, CA, USA). TaqMan probes were as follows: Runx2 
(Mm00501584_m1), Osterix (Mm04209856_m1), Col1α1 (Mm00801666_g1). GAPDH 
(Mm03302249_g1) was used as the internal control for normalization of target gene expression. 
 
Statistical analysis 
Results are presented as means ± standard deviation (SD). Statistical analysis was 




Effect of Pro-Hyp on MC3T3-E1 cell proliferation 
We evaluated whether Pro-Hyp treatment could enhance proliferation of MC3T3-E1 cells. 
MC3T3-E1 cells were cultured with 0.01–1 mM Pro-Hyp for 2 days and cell growth was measured 
using the WST-1 assay. The OD450 value for the control without Pro-Hyp was 0.79±0.012. In the 
presence of 0.01, 0.1, and 1 mM of Pro-Hyp, the OD450 values were 0.79±0.017, 0.081±0.013, and 
0.79±0.026, respectively. No significant differences were observed between the control and 
Pro-Hyp-treated cells (Figure 1). 
 
Effect of Pro-Hyp on ALP activity in MC3T3-E1 cells 
We examined the effect of Pro-Hyp on ALP activity as a marker of osteoblast 
differentiation. MC3T3-E1 cells were cultured in the presence of 0, 0.1, or 1 mM Pro-Hyp for 5 days 
and cell differentiation was measured by ALP staining. The stained areas of the 0.1 and 1 mM 
Pro-Hyp-treated cells increased about 2.1- and 5.6-fold, respectively, compared with the untreated 
ODM-only control cells (p<0.05, Figure 2). 
 
Effect of Pro-Hyp on mineralization of MC3T3-E1 cells 
To examine the effect of Pro-Hyp on osteoblast mineralization, MC3T3-E1 cells were 
cultured with ODM in the presence of 0, 0.1, and 1 mM Pro-Hyp for 21 days. Osteoblast 
mineralization was measured by Von Kossa staining. Mineralized nodules in the 0.1 and 1 mM 
Pro-Hyp-treated cells were increased about 1.37- and 1.07-fold compared with the untreated 
ODM-only control cells (Figure 3). 
 
Effect of Pro-Hyp on gene expression of Runx2, Osterix, and Col1α1 in MC3T3-E1 cells 
To examine the effect of Pro-Hyp on osteoblastic gene expression in MC3T3-E1 cells, 
MC3T3-E1 cells were cultured with ODM in the presence of 0, 0.1, and 1 mM Pro-Hyp for 3 h and 
osteoblastic gene expression was determined by quantitative real-time PCR. 
Runx2 and Osterix mRNA levels were increased in a dose-dependent manner in the 
presence of Pro-Hyp. Expression of Runx2 increased about 1.43- and 2.21-fold in the 0.1 and 1 mM 
Pro-Hyp-treated groups, respectively, compared with the control (p<0.05, Figure 4A). The 
expression of Osterix increased about 1.41- and 2.88-fold in the 0.1 and 1 mM Pro-Hyp-treated 
groups, respectively, compared with the control (p<0.05, Figure 4B). Col1α1 mRNA level was 
increased following treatment with high concentration of Pro-Hyp. The expression of Col1α1 






In this study, we investigated the effect of Pro-Hyp on the proliferation and differentiation 
of the MC3T3-E1 osteoblastic cell line. Pro-Hyp did not affect the proliferation of MC3T3-E1 cells. 
Previous reports have shown that crude CP stimulates the proliferation of osteoblast cells. In one 
previous report, crude CP was used that may include various collagen-derived di-, tri-, and 
oligo-peptides such as Pro-Hyp, Pro-Hyp-Gly, Hyp-Gly, or Ala-Hyp [12-14]. It is speculated that 
these collagen-derived peptides, except Pro-Hyp, have the ability to enhance osteoblast proliferation. 
Further studies are necessary to investigate the effects of other specific sequence peptides included in 
CP on the proliferation of osteoblasts. 
During the osteoblast differentiation phase, osteoblasts synthesize type 1 collagen, ALP, 
and various non-collagen proteins that are associated with matrix mineralization. ALP is a marker 
enzyme of early-stage osteoblast differentiation. Mineralized nodules appear as a marker of 
late-stage osteoblast differentiation [17-20]. We revealed that Pro-Hyp could significantly increase 
ALP activity in MC3T3-E1 cells compared with the control. This result suggests that Pro-Hyp 
enhanced osteoblast differentiation during the early stage. However, the formation of mineralized 
nodules in the MC3T3-E1 cells was not affected by the addition of Pro-Hyp. A previous study has 
shown that crude CP increases the collagen content in osteoblast cell cultures and promotes matrix 
mineralization [12]. Further studies are necessary to investigate the cooperative effect of Pro-Hyp 
and other di-, tri-, and oligo-peptides that are included in CPo promote matrix mineralization in 
MC3T3-E1 cells. 
In addition, we examined the effects of Pro-Hyp on the regulation of osteoblast-associated 
genes. Runx2 is a transcription factor that regulates the differentiation of osteoblasts and the 
expression of Col1α1 and other extracellular matrix protein genes during bone formation [21]. 
Osterix is also an essential transcription factor for osteoblast differentiation [22]. We found Pro-Hyp 
significantly up-regulated Runx2, Osterix and Col1α1 mRNA levels in MC3T3-E1 cells compared 
with the control. Furthermore, Runx2 and Osterix mRNA levels were significantly increased with 
addition of lower concentrations of Pro-Hyp. These results indicate that Pro-Hyp can promote the 
differentiation of osteoblasts by upregulating gene expression of Runx2 and Osterix. Previous reports 
have shown that treatment with crude CP increases the expression of the Runx2 and the Col1α1 
genes in osteoblastic cells [13,14]. The regulation by Pro-Hyp in MC3T3-E1 cells would explain a 
mechanism of the protective effect of CP in bone metabolism.  
In conclusion, this study demonstrates for the first time that Pro-Hyp, containing 
food-derived collagen hydrolysate and collagen metabolites in the blood, has a positive effect on 
osteoblast differentiation. These results indicate that bone formation is modulated by CP from oral 
ingestion (exogenous) or bone metabolites (endogenous). These findings indicate the potential utility 
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Figure 1. Effect of Pro-Hyp on MC3T3-E1 cell proliferation. MC3T3-E1 cells were treated with 
Pro-Hyp at 0.01–1 mM for 2 days. MC3T3-E1 cell proliferation was measured using the WST-1 
assay. Data are presented as means ± SD (n=4).  
 
Figure 2. Effect of Pro-Hyp on MC3T3-E1 alkaline phosphatase (ALP) activity. MC3T3-E1 cells 
were cultured for 5 days in osteoblast differentiation medium (ODM) with 0.1 or 1 mM of Pro-Hyp. 
ALP stained areas were scanned and analyzed qualitatively. (A) The scanned images show ALP 
staining in MC3T3-E1 cells in the presence or absence of Pro-Hyp (0.1 and 1 mM). The scale bar 
represents 1 mm. (B) ALP staining was evaluated using Image J software. Data are presented as 
means ± SD (n=4), *p<0.05. 
 
Figure 3. Effect of Pro-Hyp on mineralization of MC3T3-E1 cells. MC3T3-E1 cells were cultured 
for 21 days in osteoblast differentiation medium (ODM) with 0.1 or 1 mM of Pro-Hyp. The 
mineralized nodules were scanned and analyzed qualitatively. (A) The scanned images show Von 
Kossa staining in MC3T3-E1 cells in the presence or absence of Pro-Hyp (0.1 and 1 mM). The scale 
bar represent 10 mm. (B) Mineralized nodules were evaluated using Image J software. Data are 
presented as means ± SD (n=3), *p<0.05. 
 
Figure 4. Effect of Pro-Hyp on mRNA expression levels of Runx2, Osterix and Col1α1 in 
MC3T3-E1 cells, analyzed by RT-PCR. After 3 days culture, medium was replaced with identical 
medium containing 0.1 or 1 mM of Pro-Hyp. Cells were cultured with or without Pro-Hyp for 3 h. 
RT-PCR analysis of the expression levels of Runx2 (A), Osterix (B), and Col1α1 (C) mRNA levels 
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